{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:13Z","timestamp":1793678413358,"version":"4.5.1"},"reference-count":27,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dyskeratosis congenita (DC) is a pediatric bone marrow failure syndrome caused by germline mutations in telomere biology genes. Mutations in DKC1 (the most commonly mutated gene in DC), the 3\u2032 region of TERC, and poly(A)-specific ribonuclease (PARN) cause reduced levels of the telomerase RNA component (TERC) by reducing its stability and accelerating TERC degradation. We have previously shown that depleting wild-type DKC1 levels by RNA interference or expression of the disease-associated A353V mutation in the DKC1 gene leads to decay of TERC, modulated by 3\u2032-end oligoadenylation by noncanonical poly(A) polymerase 5 (PAPD5) followed by 3\u2032 to 5\u2032 degradation by EXOSC10. Furthermore, the constitutive genetic silencing of PAPD5 is sufficient to rescue TERC levels, restore telomerase function, and elongate telomeres in DKC1_A353V mutant human embryonic stem cells (hESCs). Here, we tested a novel PAPD5\/7 inhibitor (RG7834), which was originally discovered in screens against hepatitis B viral loads in hepatic cells. We found that treatment with RG7834 rescues TERC levels, restores correct telomerase localization in DKC1 and PARN-depleted cells, and is sufficient to elongate telomeres in DKC1_A353V hESCs. Finally, treatment with RG7834 significantly improved definitive hematopoietic potential from DKC1_A353V hESCs, indicating that the chemical inhibition of PAPD5 is a potential therapy for patients with DC and reduced TERC levels.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001848","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T11:39:30Z","timestamp":1592566770000},"page":"2717-2722","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Chemical inhibition of PAPD5\/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita"],"prefix":"10.1182","volume":"4","author":[{"given":"Siddharth","family":"Shukla","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Colorado Boulder, Boulder, CO;"},{"name":"Howard Hughes Medical Institute, Chevy Chase, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-8314","authenticated-orcid":false,"given":"Ho-Chang","family":"Jeong","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Sturgeon","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Center of Regenerative Medicine, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-4152","authenticated-orcid":false,"given":"Roy","family":"Parker","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Colorado Boulder, Boulder, CO;"},{"name":"Howard Hughes Medical Institute, Chevy Chase, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Francisco Zirnberger","family":"Batista","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Center of Regenerative Medicine, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"2020061911392695700_B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12688\/f1000research.14068.1","article-title":"Beginning at the ends: telomeres and human disease","volume":"7","author":"Savage","year":"2018","journal-title":"F1000 Res"},{"issue":"6","key":"2020061911392695700_B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/07853890.2014.915579","article-title":"Inherited bone marrow failure syndromes in adolescents and young adults","volume":"46","author":"Wilson","year":"2014","journal-title":"Ann Med"},{"issue":"4","key":"2020061911392695700_B3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hoc.2018.04.003","article-title":"Evaluation and management of hematopoietic failure in dyskeratosis congenita","volume":"32","author":"Agarwal","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2020061911392695700_B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2020061911392695700_B5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","article-title":"Advances in the understanding of dyskeratosis congenita","volume":"145","author":"Walne","year":"2009","journal-title":"Br J Haematol"},{"issue":"10","key":"2020061911392695700_B6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes [published correction appears in Nat Rev Genet. 2013;14(3):235]","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2020061911392695700_B7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI78963","article-title":"Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita","volume":"125","author":"Tummala","year":"2015","journal-title":"J Clin Invest"},{"issue":"5","key":"2020061911392695700_B8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"2020061911392695700_B9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/jmedgenet-2015-103292","article-title":"Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)","volume":"52","author":"Dhanraj","year":"2015","journal-title":"J Med Genet"},{"issue":"351","key":"2020061911392695700_B10","doi-asserted-by":"crossref","first-page":"351ra107","DOI":"10.1126\/scitranslmed.aaf7837","article-title":"Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema","volume":"8","author":"Stanley","year":"2016","journal-title":"Sci Transl Med"},{"issue":"6761","key":"2020061911392695700_B11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"issue":"1","key":"2020061911392695700_B12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"issue":"4","key":"2020061911392695700_B13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nsmb.3184","article-title":"Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects","volume":"23","author":"Shukla","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"2020061911392695700_B14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/ng.3423","article-title":"Poly(A)-specific ribonuclease (PARN) mediates 3\u2032-end maturation of the telomerase RNA component","volume":"47","author":"Moon","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"2020061911392695700_B15","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1172\/JCI87547","article-title":"Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease","volume":"126","author":"Boyraz","year":"2016","journal-title":"J Clin Invest"},{"issue":"10","key":"2020061911392695700_B16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.celrep.2015.10.075","article-title":"Human telomerase RNA processing and quality control","volume":"13","author":"Tseng","year":"2015","journal-title":"Cell Rep"},{"issue":"4","key":"2020061911392695700_B17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.molcel.2019.02.033","article-title":"Disruption of telomerase RNA maturation kinetics precipitates disease","volume":"74","author":"Roake","year":"2019","journal-title":"Mol Cell"},{"issue":"12","key":"2020061911392695700_B18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2018-11-885368","article-title":"Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita","volume":"133","author":"Fok","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2020061911392695700_B19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"2020061911392695700_B20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"PAPD5\/7 are host factors that are required for hepatitis B virus RNA stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"2020061911392695700_B21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.stemcr.2017.06.015","article-title":"p53 Mediates failure of human definitive hematopoiesis in dyskeratosis congenita","volume":"9","author":"Fok","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"5914","key":"2020061911392695700_B22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1165357","article-title":"A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis","volume":"323","author":"Venteicher","year":"2009","journal-title":"Science"},{"issue":"1","key":"2020061911392695700_B23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1091\/mbc.e03-07-0525","article-title":"Telomerase RNA accumulates in cajal bodies in human cancer cells","volume":"15","author":"Zhu","year":"2004","journal-title":"Mol Biol Cell"},{"issue":"6","key":"2020061911392695700_B24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nbt.2915","article-title":"Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells","volume":"32","author":"Sturgeon","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2020061911392695700_B25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI67146","article-title":"Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs","volume":"123","author":"Winkler","year":"2013","journal-title":"J Clin Invest"},{"key":"2020061911392695700_B26","doi-asserted-by":"crossref","first-page":"101540","DOI":"10.1016\/j.scr.2019.101540","article-title":"Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells","volume":"40","author":"Donaires","year":"2019","journal-title":"Stem Cell Res (Amst)"},{"key":"2020061911392695700_B27","article-title":"Small-molecule PAPD5 inhibitors restore telomerase activity in patient stem cells [published online ahead of print 21 April 2020]","author":"Nagpal","journal-title":"Cell Stem Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2717\/1745331\/advancesadv2020001848.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2717\/1745331\/advancesadv2020001848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T11:39:45Z","timestamp":1592566785000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/12\/2717\/461025\/Chemical-inhibition-of-PAPD57-rescues-telomerase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001848","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}